Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay

Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay

Abstract Objective To assess the real‐world performance of a live (LCBA) versus a fixed (FCBA) cell‐based assay for the detection of serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG‐IgG) and aquaporin‐4 (AQP4‐IgG). Methods This was a retrospective study of patients evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: Yana Said, Angeliki Filippatou, Conlan Tran, LuAnn Rezavi, Kai Guo, Matthew D. Smith, Yasmin Resto, John J. Chen, Peter A. Calabresi, Patrizio Caturegli, Sean J. Pittock, Eoin P. Flanagan, Elias S. Sotirchos
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.52310
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/acn3.52310

Similar Items